Back

Coiled Therapeutics enrolls six patients to test reformulated AO-252 cancer drug

Verifying
  • Coiled Therapeutics enrolled six patients to test reformulated AO-252.
  • Six patients are divided between two dosing groups.
  • AO-252 uses a lipid-based softgel designed to cross the brain better.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Coiled Therapeutics enrolls six patients to test reformulated AO-252 cancer drug - CoinPost Terminal